sanofi, KaloBios in infectious deal

KaloBios Pharmaceuticals Inc. (South San Francisco, Calif.) granted Sanofi Pasteur S.A. exclusive, worldwide rights to develop and commercialize KB001 to treat and prevent Pseudomonas aeruginosa infe...